18F-FDG PET imaging for monitoring the early anti-tumor effect of albendazole on triple-negative breast cancer

Occurrence of the potent mutagens 2- nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles

(2019) Aldenor G. Santos et al.   Scientific Reports

Role of mitochondria in rescuing glycolytically inhibited subpopulation of triple negative but not hormone-responsive breast cancer cells

(2019) Asmaa Reda et al.   Scientific Reports

Theranostics of Triple-Negative Breast Cancer Based on Conjugated Polymer Nanoparticles

(2018) Guorui Jin et al.   ACS Applied Materials & Interfaces

Albendazole inhibits HIF-1α-dependent glycolysis and VEGF expression in non-small cell lung cancer cells

(2017) Fang Zhou et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport

(2017) Arvindhan Nagarajan et al.   MOLECULAR CELL

Anthelmintic drug albendazole arrests human gastric cancer cells at the mitotic phase and induces apoptosis

(2016) Xuan Zhang et al.   Experimental and Therapeutic Medicine

18F-FDG PET/CT for Monitoring the Response of Breast Cancer to miR-143-Based Therapeutics by Targeting Tumor Glycolysis

(2016) Ying Miao et al.   Molecular Therapy-Nucleic Acids

Dual tumor targeting with pH-sensitive and bioreducible polymer-complexed oncolytic adenovirus

(2015) Chang Yoon Moon et al.   BIOMATERIALS

Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data

(2015) Marianne Paesmans et al.   EUROPEAN RESPIRATORY JOURNAL

Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress

(2015) YOON-MI LEE et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Dimeric Drug Polymeric Nanoparticles with Exceptionally High Drug Loading and Quantitative Loading Efficiency

(2015) Kaimin Cai et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model

(2015) Lubna Noorani et al.   JOURNAL OF NANOBIOTECHNOLOGY

Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model

(2015) Cornelia Braicu et al.   PLoS One

Glut-1 Expression Correlates with Basal-like Breast Cancer

(2014) Yaser R. Hussein et al.   Translational Oncology

Combination of Albendazole and 2-Methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice

(2013) Anahid Ehteda et al.   BMC CANCER

The rebel angel: mutant p53 as the driving oncogene in breast cancer

(2012) D. Walerych et al.   CARCINOGENESIS

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

(2012) Sohrab P. Shah et al.   NATURE

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

LKB1/AMPK/mTOR signaling pathway in hematological malignancies: From metabolism to cancer cell biology

(2011) Alexa S. Green et al.   CELL CYCLE

Albendazole sensitizes cancer cells to ionizing radiation

(2011) Kirtesh Patel et al.   Radiation Oncology